Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features
Year: 2026
Type: article
Study design: Observational Study
Abstract: Ovarian carcinoma (OC) is one of the most lethal gynecological malignancies. Galectin-8 (Gal-8) and the VEGF-C/VEGFR-3 lymphangiogenic axis have each been implicated in OC progression, but they have not been examined together in a histotype-resolved series. In this retrospective, cross-sectional, single-center study of 84 epithelial OC cases, Gal-8, VEGF-C and VEGFR-3 immunoexpression was related to histological type, Type I/Type II classification, pT-based stage and residual disease, with correction for multiple testing (q). Gal-8 was nuclear in all 34 high-grade serous carcinomas (HGSCs) and all 42 Type II tumors, whereas cytoplasmic and mixed patterns occurred almost only in low-grade and Type I tumors. A high Gal-8 score was associated with HGSC and Type II histology, poor differentiation, advanced stage and residual disease (odds ratios, all q ≤ 0.004). VEGF-C and VEGFR-3 were expressed in 67.86% and 73.81% of cases, more often in high-grade and advanced tumors, and in all stage III tumors. No statistically significant association was detected between Gal-8 and VEGF-C or VEGFR-3, but the cohort was too small for this comparison to be conclusive. Gal-8, VEGF-C and VEGFR-3 are each associated with aggressive features of OC. This study cannot show whether this reflects a shared aggressive phenotype or a functional interaction between the markers. Without outcome data or multivariable analysis, these findings are descriptive, not prognostic, and hypothesis-generating.
DOI: 10.3390/cimb48111243
Authors: Elena-Roxana Avădănei(Conceptualization, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing), Irina-Draga Căruntu(Data curation, Formal analysis, Supervision, Validation, Visualization), Ioana Păvăleanu(Formal analysis, Investigation, Project administration, Resources), Andreea Ioana Pruteanu(Data curation, Methodology, Resources, Visualization), Simona-Eliza Giușcă(Formal analysis, Funding acquisition, Supervision, Visualization), Andreea Rusu(Methodology, Validation, Writing – original draft, Writing – review & editing), Gabriela Bordeianu(Data curation, Funding acquisition, Methodology, Supervision), Ovidiu Bîcă(Funding acquisition, Resources, Software), Ludmila Lozneanu(Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing)
Institution: Grigore T. Popa University of Medicine and Pharmacy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7236277161
